Cargando…
Suspected accelerated disease progression after discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: Two case reports
RATIONAL: The efficacy of nintedanib, a multitarget receptor tyrosine kinase inhibitor, has been demonstrated in recent randomized controlled trials involving patients with idiopathic pulmonary fibrosis (IPF). However, accelerated disease progression after nintedanib discontinuation has never been r...
Autores principales: | Okamori, Satoshi, Asakura, Takanori, Masuzawa, Keita, Yasuda, Hiroyuki, Kamata, Hirofumi, Ishii, Makoto, Betsuyaku, Tomoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728940/ https://www.ncbi.nlm.nih.gov/pubmed/29245325 http://dx.doi.org/10.1097/MD.0000000000009081 |
Ejemplares similares
-
ALK-positive lung adenocarcinoma in a patient with rheumatoid arthritis with long-term treatment for organizing pneumonia: A case report
por: Horie, Kazuhito, et al.
Publicado: (2022) -
Sternoclavicular joint osteomyelitis extending to lung abscess complicated by Staphylococcal infective endocarditis
por: Masuzawa, Keita, et al.
Publicado: (2017) -
Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration
por: Ikeda, Satoshi, et al.
Publicado: (2022) -
Disseminated histoplasmosis from a calcified lung nodule after long-term corticosteroid therapy in an elderly Japanese patient: A case report
por: Kobayashi, Keigo, et al.
Publicado: (2019) -
Pneumothorax associated with nontuberculous mycobacteria: A retrospective study of 69 patients
por: Ueyama, M, et al.
Publicado: (2016)